Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Edwards Lifesciences Corp (NYSE:EW) reported strong financial results for the fourth quarter of 2024, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $0.59 against a ...

Group reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an EPS of $0.27 against a forecast of $0.23. The company also reported revenue of $328.44 million, slightly above ...